Paulson Acquires Stake In Salix Amid Inventory Pileup ConcernsMani
Famous investment firm Paulson & Co has acquired an undisclosed stake in Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) as the drug maker recovers from inventory pileup issues and the exit of its chief financial officer.
Paulson & Co’s acquisition in Salix headlines its health-care holdings, as it is also the third-biggest shareholder of Shire Plc.
Paulson’s stake in Salix
Citing people familiar with the developments, Olivia Oran . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.